Currently, there are 329.16M common shares owned by the public and among those 324.71M shares have been available to trade.
The company’s stock has a 5-day price change of 0.18% and 6.32% over the past three months. JNPR shares are trading 31.89% year to date (YTD), with the 12-month market performance up to 39.91% higher. It has a 12-month low price of $24.87 and touched a high of $39.79 over the same period. JNPR has an average intraday trading volume of 2.83 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.37%, 1.01%, and 7.12% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Juniper Networks Inc (NYSE: JNPR) shares accounts for 87.42% of the company’s 329.16M shares outstanding.
It has a market capitalization of $12.80B and a beta (3y monthly) value of 0.92. The stock’s trailing 12-month PE ratio is 54.15, while the earnings-per-share (ttm) stands at $0.72. The company has a PEG of 4.92 and a Quick Ratio of 1.23 with the debt-to-equity ratio at 0.38. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.84% over the week and 0.66% over the month.
Earnings per share for the fiscal year are expected to decrease by -28.57%, and 20.84% over the next financial year. EPS should grow at an annualized rate of 11.00% over the next five years, compared to -9.86% over the past 5-year period.
Looking at the support for the JNPR, a number of firms have released research notes about the stock. Citigroup stated their Neutral rating for the stock in a research note on September 24, 2024, with the firm’s price target at $40. JP Morgan was of a view on October 10, 2023 that the stock is Neutral, while Raymond James gave the stock Outperform rating on July 24, 2023, issuing a price target of $38- $37. Exane BNP Paribas on their part issued Neutral rating on July 20, 2023.
